Understanding Cervicothoracic Epidural Injections and Clinical Utility

Interventional spine specialists frequently utilize cervicothoracic epidural injections to manage chronic cervical radiculopathy, axial neck pain, and upper extremity paresthesias. These therapeutic procedures effectively deliver anti-inflammatory corticosteroids directly into the epidural space. Consequently, clinicians reduce localized nerve root inflammation and alleviate debilitating symptoms in affected patients. Two primary anatomical approaches exist for delivering this medication: the interlaminar (IL) approach and the transforaminal (TF) approach. Although both techniques aim to provide targeted pain relief, their safety profiles remain a subject of active discussion among spine care specialists. Historically, clinicians selected the technique based on institutional training, personal familiarity, and specific patient anatomical variations. However, growing concerns regarding potential neurological complications have prompted researchers to evaluate the safety profiles of both techniques using large national datasets. Consequently, establishing precise evidence regarding procedure-related risks is crucial for guiding clinical practice, optimizing patient safety, and informing informed consent discussions in interventional pain medicine.

Analyzing Interlaminar versus Transforaminal Procedural Approaches

The technical execution of interlaminar and transforaminal injections differs significantly in needle trajectory and target delivery site. Specifically, the interlaminar approach introduces the needle posteriorly between adjacent vertebral laminae, depositing injectate broadly into the dorsal epidural space. In contrast, the transforaminal technique directs the needle anterolaterally into the intervertebral foramen, targeting the specific nerve root exit zone directly. Therefore, transforaminal delivery often provides higher local corticosteroid concentrations to the affected spinal nerve. However, this anterolateral trajectory traverses anatomical zones containing critical arterial structures, including the vertebral artery and radiculomedullary branches. Consequently, accidental intra-arterial placement or particulate steroid embolization can lead to catastrophic neurological injuries, such as brainstem or spinal cord infarction. On the other hand, interlaminar injections carry potential risks of dural puncture, spinal cord compression, or epidural hematoma formation. As a result, interventional pain physicians continuously debate which technique yields superior therapeutic benefits while minimizing neurological risk. Understanding these procedural distinctions is fundamental when selecting the optimal approach for individual clinical scenarios.

Key Study Findings on Neurological Adverse Event Rates

To clarify national complication trends, a landmark retrospective cohort study analyzed database records from over 1.29 million patients undergoing epidural injections. The dataset included 1,073,215 interlaminar procedures and 220,597 transforaminal procedures across a national multi-insurance population. Researchers tracked post-injection neurological adverse events occurring within 48 hours following the procedure. Overall, the absolute incidence of neurological complications remained low for both approaches. Specifically, interlaminar injections demonstrated a complication rate of 4.15 per 1,000 patients, whereas transforaminal injections showed a rate of 4.56 per 1,000 patients. Statistical analysis confirmed that this overall difference was not significant (P = 0.889). Consequently, the study demonstrated that both techniques possess comparable overall neurological safety profiles at a national population level. These findings offer reassuring evidence for interventionalists, confirming that devastating neurological events are relatively rare across both procedural approaches. Nevertheless, the study also revealed subtle, specific risk variations between the two methods that warrant detailed clinical attention.

Specific Risk Profiles and Nerve Root Injury Associations

Although the overall incidence of complications appeared similar, multivariable logistic regression analysis revealed notable differences in specific adverse event profiles. After controlling for confounding factors such as age, sex, and Elixhauser comorbidity index, transforaminal injections demonstrated a statistically significant higher risk of nerve root injury. Specifically, transforaminal procedures were associated with a 69% increase in the odds of nerve root injury relative to interlaminar injections (OR: 1.69). This increased risk likely stems from the close proximity of the needle tip to sensitive neural structures within the neuroforamen. Conversely, interlaminar injections did not show an elevated risk for nerve root trauma, but they carried distinct inherent risks related to dorsal space access. Furthermore, odds ratios for other individual neurological complications, including spinal cord injury and cerebrovascular events, did not differ significantly between the two cohorts. Therefore, while both techniques carry low absolute risk, clinicians must recognize that each approach is independently linked to distinct complication risks.

Clinical Implications for Interventional Spine Practitioners

These nationwide population findings provide valuable guidance for practicing interventional spine specialists, anesthesiologists, and pain management physicians. Importantly, the evidence challenges the clinical assumption that one specific cervicothoracic approach is universally safer than the other. Instead, practitioners must evaluate each patient's individual anatomical features, structural pathology, and underlying comorbidities prior to selecting an injection technique. For example, in patients with severe neuroforaminal stenosis, transforaminal needle placement may heighten the risk of mechanical nerve root contact or vascular injury. In such cases, an interlaminar approach may offer a safer alternative for delivering epidural steroids. Conversely, in patients with prior posterior cervical spine fusion or laminectomy, epidural scarring increases the risk of inadvertent dural puncture during interlaminar access. Consequently, a transforaminal approach might be preferable despite its higher nerve root injury odds. Ultimately, procedural selection should rely on comprehensive pre-procedure imaging analysis, clear patient communication, and careful balancing of anatomical risks against therapeutic goals.

Optimizing Patient Selection and Technical Precautions

To maximize patient safety during cervicothoracic epidural procedures, interventionalists should implement strict technical precautions and evidence-based safeguards. First, performing all injections under continuous live fluoroscopic guidance with digital subtraction angiography helps identify inadvertent intravascular contrast spread promptly. Second, utilizing non-particulate corticosteroids, such as dexamethasone, substantially reduces the risk of embolic infarction during transforaminal procedures. Third, maintaining minimal sedation allows patients to report immediate paresthesias or pain upon needle placement, preventing direct nerve root or spinal cord trauma. Additionally, clinicians must thoroughly review patient medication profiles, ensuring appropriate management of anticoagulant and antiplatelet therapies prior to spinal interventions. Furthermore, clear documentation of informed consent regarding procedural risks fosters transparent patient communication and shared decision-making. By combining careful patient selection, precise imaging guidance, and meticulous technique, clinicians can effectively deliver cervical epidural therapy while minimizing neurological complications. Overall, adherence to established safety protocols ensures optimal therapeutic outcomes across diverse patient populations.

Frequently Asked Questions

What are the primary differences between interlaminar and transforaminal epidural injections?

The interlaminar approach introduces a needle posteriorly between vertebral laminae into the dorsal epidural space, spreading medication broadly. Conversely, the transforaminal approach directs the needle anterolaterally into the intervertebral foramen, delivering targeted steroid medication directly adjacent to the exit root. Both techniques effectively treat cervical radiculopathy but utilize distinct anatomical trajectories.

How do overall neurological complication rates compare between the two injection techniques?

Large-scale national data demonstrates that overall neurological complication rates are low and comparable between both procedures. Interlaminar injections exhibit a rate of approximately 4.15 per 1,000 patients, whereas transforaminal injections show 4.56 per 1,000 patients. Statistical evaluation confirms no significant overall difference in total risk between these two approaches.

Which specific neurological adverse event is higher with transforaminal injections?

Transforaminal injections carry a significantly higher odds ratio for nerve root injury compared to interlaminar injections. Specifically, studies indicate a 69% increased risk of nerve root trauma following transforaminal procedures. This elevated risk relates directly to the close mechanical proximity between the needle tip and the nerve root within the neuroforamen.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Seddio AE et al. Comparable Overall Risk of Neurological Adverse Events Following Cervicothoracic Interlaminar and Transforaminal Epidural Injections: An Analysis of 1.29 Million Patients. Spine (Phila Pa 1976). 2025 Sep 15. doi: 10.1097/BRS.0000000000005181. PMID: 39394649.


2. Manchikanti L et al. Major risks and complications of cervical epidural steroid injections: An updated review. Surg Neurol Int. 2018;9:86.


3. Rathmell JP et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus guidelines from a multidisciplinary working group. Anesthesiology. 2015;122(5):974-984.